SCHEMBL695071

SCHEMBL695071

NC(=O)C1CCCN1S(=O)(=O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.59
MMP9 P14780 2/20 0.59
FKBP1A P62942 3/20 0.56
LMNA P02545 3/20 0.53
MAPT P10636 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
ALDH1A1 P00352 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
GAA P10253 1/20 0.53
HTT P42858 1/20 0.51
GHSR Q92847 2/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C19 P33261 1/20 0.51
RAB9A P51151 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17833176 1.00 MMP2 (0.59) MMP2MMP9FKBP1ALMNAMAPT
SCHEMBL8718942 0.95 LMNA (0.58) MMP2MMP9FKBP1ALMNAMAPT
SCHEMBL23519421 0.87 ALDH1A1 (0.65) MMP2MMP9FKBP1ALMNAMAPT
SCHEMBL6997 0.87 ALDH1A1 (0.65) MMP2MMP9FKBP1ALMNAMAPT
SCHEMBL6996 0.87 ALDH1A1 (0.65) MMP2MMP9FKBP1ALMNAMAPT
Water SCHEMBL28790504 0.86 ALDH1A1 (0.63) MMP2MMP9FKBP1ALMNAMAPT
SCHEMBL15538805 0.85 GHSR (0.60) MMP2MMP9FKBP1AALDH1A1SMN1; SMN2
SCHEMBL28864063 0.85 LMNA (0.63) LMNAMAPTALDH1A1SMN1; SMN2GAA
SCHEMBL10433913 0.85 GAA (0.63) FKBP1AMAPTALDH1A1GAA
SCHEMBL19563393 0.85 PLAU (0.50) MMP2MMP9LMNAALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421826-A1 PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-02-29 EP claimed
WO-2010121918-A1 PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-10-28 WO claimed
WO-2012152983-A1 PHENYL- SULFONYL DERIVATIVES AS MEDIATORS OF TRPA1 RECEPTOR ACTIVITY FOR THE TREATMENT OF PAIN ORION CORPORATION (FI) 2012-11-15 WO disclosed
EP-2520566-A1 New Pharmaceutical Compounds Orion Corporation (FI) 2012-11-07 EP disclosed